Paliperidone Palmitate
Paliperidone Palmitate Extended-Release Injectable Suspension
Approved
Approval ID
a08ab93b-0bac-42fd-8357-d10a49301b72
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 9, 2024
Manufacturers
FDA
TOLMAR Inc.
DUNS: 791156578
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Paliperidone Palmitate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63646-710
Product Classification
G
Generic Name
Paliperidone Palmitate
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification
Paliperidone Palmitate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63646-711
Product Classification
G
Generic Name
Paliperidone Palmitate
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification
Paliperidone Palmitate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63646-712
Product Classification
G
Generic Name
Paliperidone Palmitate
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification
Paliperidone Palmitate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63646-713
Product Classification
G
Generic Name
Paliperidone Palmitate
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification
Paliperidone Palmitate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63646-714
Product Classification
G
Generic Name
Paliperidone Palmitate
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification